219 related articles for article (PubMed ID: 3613021)
1. The relationship of tampon characteristics to menstrual toxic shock syndrome.
Berkley SF; Hightower AW; Broome CV; Reingold AL
JAMA; 1987 Aug; 258(7):917-20. PubMed ID: 3613021
[TBL] [Abstract][Full Text] [Related]
2. Toxic shock syndrome: an update.
Reingold AL
Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1236-9. PubMed ID: 1951580
[TBL] [Abstract][Full Text] [Related]
3. Tri-state toxic-state syndrome study. I. Epidemiologic findings.
Osterholm MT; Davis JP; Gibson RW; Mandel JS; Wintermeyer LA; Helms CM; Forfang JC; Rondeau J; Vergeront JM
J Infect Dis; 1982 Apr; 145(4):431-40. PubMed ID: 7069223
[TBL] [Abstract][Full Text] [Related]
4. Vaginal tampon model for toxic shock syndrome.
Melish ME; Murata S; Fukunaga C; Frogner K; McKissick C
Rev Infect Dis; 1989; 11 Suppl 1():S238-46; discussion S246-7. PubMed ID: 2928642
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for development of toxic shock syndrome. Association with a tampon brand.
Schlech WF; Shands KN; Reingold AL; Dan BB; Schmid GP; Hargrett NT; Hightower A; Herwaldt LA; Neill MA; Band JD; Bennett JV
JAMA; 1982 Aug; 248(7):835-9. PubMed ID: 7097945
[TBL] [Abstract][Full Text] [Related]
6. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.
Shands KN; Schmid GP; Dan BB; Blum D; Guidotti RJ; Hargrett NT; Anderson RL; Hill DL; Broome CV; Band JD; Fraser DW
N Engl J Med; 1980 Dec; 303(25):1436-42. PubMed ID: 7432402
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for menstrual toxic shock syndrome: results of a multistate case-control study.
Reingold AL; Broome CV; Gaventa S; Hightower AW
Rev Infect Dis; 1989; 11 Suppl 1():S35-41; discussion S41-2. PubMed ID: 2928651
[TBL] [Abstract][Full Text] [Related]
8. Toxic shock syndrome in Canada.
Clayton AJ; Peacocke JE; Ewan PE
Can Med Assoc J; 1982 Apr; 126(7):776-9. PubMed ID: 7042059
[TBL] [Abstract][Full Text] [Related]
9. Toxic shock syndrome: relation to catamenial products, personal health and hygiene, and sexual practices.
Osterholm MT; Davis JP; Gibson RW; Forfang JC; Stolz SJ; Vergeront JM
Ann Intern Med; 1982 Jun; 96(6 Pt 2):954-8. PubMed ID: 7091973
[TBL] [Abstract][Full Text] [Related]
10. Emerging patterns of tampon use in the adolescent female: the impact of toxic shock syndrome.
Irwin CE; Millstein SG
Am J Public Health; 1982 May; 72(5):464-7. PubMed ID: 7065334
[TBL] [Abstract][Full Text] [Related]
11. Toxic shock and tampons. Evaluation of the epidemiologic evidence.
Harvey M; Horwitz RI; Feinstein AR
JAMA; 1982 Aug; 248(7):840-6. PubMed ID: 7047782
[TBL] [Abstract][Full Text] [Related]
12. Toxic-shock syndrome, United States, 1970-1982.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1982 Apr; 31(16):201-4. PubMed ID: 6804780
[TBL] [Abstract][Full Text] [Related]
13. Medical devices; labeling for menstrual tampons; ranges of absorbency, change from "junior" to "light." Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 Aug; 69(164):52170-1. PubMed ID: 15329983
[TBL] [Abstract][Full Text] [Related]
14. Toxic shock syndrome and other tampon related risks.
Cibulka NJ
JOGN Nurs; 1983; 12(2):94-9. PubMed ID: 6551545
[TBL] [Abstract][Full Text] [Related]
15. The potential of digitally inserted tampons to induce vaginal lesions.
Berkeley AS; Micha JP; Freedman KS; Hirsch JC
Obstet Gynecol; 1985 Jul; 66(1):31-5. PubMed ID: 4011068
[TBL] [Abstract][Full Text] [Related]
16. Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1.
Schlievert PM
Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):31-38. PubMed ID: 31853743
[TBL] [Abstract][Full Text] [Related]
17. Toxic shock syndrome and tampons.
Schuchat A; Broome CV
Epidemiol Rev; 1991; 13():99-112. PubMed ID: 1662639
[TBL] [Abstract][Full Text] [Related]
18. Recurrent menstrual toxic shock syndrome despite discontinuation of tampon use: is menstrual toxic shock syndrome really caused by tampons?
Dixit S; Fischer G; Wittekind C
Australas J Dermatol; 2013 Nov; 54(4):283-6. PubMed ID: 22897229
[TBL] [Abstract][Full Text] [Related]
19. The effect of publicity on the reporting of toxic-shock syndrome in Wisconsin.
Davis JP; Vergeront JM
J Infect Dis; 1982 Apr; 145(4):449-57. PubMed ID: 7069225
[TBL] [Abstract][Full Text] [Related]
20. Survey of tampon use and toxic shock syndrome, Tennessee, 1979 to 1981.
Gustafson TL; Swinger GL; Booth AL; Hutcheson RH; Schaffner W
Am J Obstet Gynecol; 1982 Jun; 143(4):369-74. PubMed ID: 7091201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
